Harriet S.MeyerMD, Contributing EditorJonathan D.EldredgeMLS, PhD, Journal Review EditorRobertHoganMD, adviser for new media
edited by David R. Guyer, Lawrence A. Yannuzzi, Stanley Chang, Jerry A. Shields, and W. Richard Green, 1543 pp, with illus, $395, ISBN 0-7216-6756-2, Philadelphia, Pa, WB Saunders Co, 1999.
In the preface to this two-volume text, the editors ask, "So why another text [on the retina and vitreous]?" The answer, in part, can be found in the foreword by Morton Goldberg, MD. He refers to the "developments of the last part of the twentieth century as a golden era in the understanding and treatment of retinal, macular and vitreous diseases."
Knowledge and understanding of vitreoretinal disease and its treatment have indeed made grand strides in the last 25 years, with the refinement of laser treatment for diseases such as diabetes and venous occlusion, through landmark national collaborative studies, vitrectomy surgery, vitreous substitutes, and endophthalmitis management. Our understanding of retinal disease has also been aided by recent diagnostic advances, such as indocyanine-green angiography, ocular coherent tomography, and molecular genetic discoveries in hereditary retinal conditions. Retina-Vitreous-Macula represents a major effort by the authors to elucidate our current knowledge of the pathophysiology and treatment of vitreoretinal disease. Moreover, they accomplish this differently from other texts by interspersing high-quality color fundus photography of virtually every retinal disease with histologic photomicrographs providing clinicopathologic correlations.
OphthalmologyRetina-Vitreous-Macula, vols 1-2. JAMA. 1999;282(7):695-696. doi:10.1001/jama.282.7.695-JBK0818-2-1